Sorrento Therapeutics, Inc.
Antibody drug conjugates
Last updated:
Abstract:
There is disclosed a Dolastatin derivative, conjugated to an antibody, comprising a Dolastatin derivative moiety of Formula IV.
Status:
Grant
Type:
Utility
Filling date:
28 Jan 2016
Issue date:
17 Mar 2020